These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36310109)

  • 1. SAR exploration of the non-imidazole histamine H
    Wágner G; Mocking TAM; Ma X; Slynko I; Da Costa Pereira D; Breeuwer R; Rood NJN; van der Horst C; Vischer HF; de Graaf C; de Esch IJP; Wijtmans M; Leurs R
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200451. PubMed ID: 36310109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor.
    Shi Y; Sheng R; Zhong T; Xu Y; Chen X; Yang D; Sun Y; Yang F; Hu Y; Zhou N
    PLoS One; 2012; 7(8):e42185. PubMed ID: 22870296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N (α)-Methylated phenylhistamines exhibit affinity to the hH(4)R-a pharmacological and molecular modelling study.
    Wittmann HJ; Elz S; Seifert R; Straber A
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):287-99. PubMed ID: 21800095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent Inhibition of the Histamine H
    Wágner G; Mocking TAM; Kooistra AJ; Slynko I; Ábrányi-Balogh P; Keserű GM; Wijtmans M; Vischer HF; de Esch IJP; Leurs R
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of histamine H₃ antagonists/inverse agonists.
    Lebois EP; Jones CK; Lindsley CW
    Curr Top Med Chem; 2011; 11(6):648-60. PubMed ID: 21261594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the antiarrhythmic drugs amiodarone and lorcainide as potent H3 histamine receptor inverse agonists.
    Del Tredici AL; Ma JN; Piu F; Burstein ES
    J Pharmacol Exp Ther; 2014 Jan; 348(1):116-24. PubMed ID: 24204014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
    Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA
    Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
    Schneider EH; Strasser A; Thurmond RL; Seifert R
    J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H
    Shinde AK; Badange RK; Reballi V; Achanta PK; Bojja K; Manchineella S; Rao Muddana N; Subramanian R; Choudary Palacharla R; Benade V; Jayarajan P; Thentu JB; Lingavarapu BB; Yarra S; Kagita N; Rao Doguparthi M; Mohammed AR; Nirogi R
    ChemMedChem; 2022 Feb; 17(3):e202100583. PubMed ID: 34761873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
    Gbahou F; Davenas E; Morisset S; Arrang JM
    J Pharmacol Exp Ther; 2010 Sep; 334(3):945-54. PubMed ID: 20530654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B; Elz S; Pertz HH; Stark H; Schunack W
    Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H3 receptor as a drug discovery target.
    Berlin M; Boyce CW; Ruiz Mde L
    J Med Chem; 2011 Jan; 54(1):26-53. PubMed ID: 21062081
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological characterization of seven human histamine H
    Gao M; Dekker ME; Leurs R; Vischer HF
    Eur J Pharmacol; 2024 Apr; 968():176450. PubMed ID: 38387718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Photoswitchable Agonist for the Histamine H
    Hauwert NJ; Mocking TAM; Da Costa Pereira D; Lion K; Huppelschoten Y; Vischer HF; De Esch IJP; Wijtmans M; Leurs R
    Angew Chem Int Ed Engl; 2019 Mar; 58(14):4531-4535. PubMed ID: 30735597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
    Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Steroid-Based Histamine H
    Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Barabás J; Béni Z; Varga B; Balázs O; Román V; Fodor L; Szikra J; Vastag M; Lévay G; Schmidt É; Lendvai B; Greiner I; Kiss B; Némethy Z; Mahó S
    J Med Chem; 2024 Mar; 67(5):3643-3667. PubMed ID: 38393759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptors.
    Sors A; Panayi F; Bert L; Favale D; Nosjean O; Audinot V; Arrang JM; Buisson B; Steidl E; Delbos JM; Huhtala T; Kontkanen O; Chollet AM; Casara P; Lestage P
    Eur J Pharmacol; 2017 May; 803():11-23. PubMed ID: 28336400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
    Ishikawa M; Watanabe T; Kudo T; Yokoyama F; Yamauchi M; Kato K; Kakui N; Sato Y
    J Med Chem; 2010 Sep; 53(17):6445-56. PubMed ID: 20690643
    [TBL] [Abstract][Full Text] [Related]